Michal Abrahamowicz
Research Scientist, Biostatistics, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage
OPTIKNEE – International team working to prevent knee osteoarthritis after knee injury
OPTIKNEE, led by Arthritis Research Canada, Research Scientist Dr. Jackie Whittaker, is an international group of over 40 scientists, patients and health care professionals working to prevent knee osteoarthritis after knee injury.
Medication used to lower cholesterol does not affect those with pre-radiographic knee osteoarthritis
A study has shown that the use of statins, traditionally utilized to lower cholesterol, is neither harmful nor beneficial to those with knee osteoarthritis.
Research Links TNF Biologics Use with Risk of Multiple Sclerosis
Researchers warn people with rheumatic diseases who have a family history of multiple sclerosis should not be taking anti-TNFα biologics after study reveals 105% increased risk of developing MS among this group of people.
Conducting Life-Changing Arthritis Research from Coast to Coast
Arthritis Research Canada expands with a new centre at Dalhousie University in Halifax, Nova Scotia and welcomes two new scientists to its cross-Canada team.
Hayley’s Story
Hayley has lived with juvenile idiopathic arthritis for almost half of her life. Now, she’s in medical school and considering how arthritis research has directly impacted her quality of life.
Computer Simulation Study Helps Assess Interventions to Reduce the Burden of Low Back Pain
A study conducted by Arthritis Research Canada sought to examine the impact of three strategies intended to reduce the burden of lower back pain (LBP) along with a secondary goal of determining the usefulness of a new microsimulation modeling software, SimYouLate.
Reducing Body Fat helps to Minimize the Risk of Developing Gout, Especially in Women
Excess weight and genetics have been linked to an increased risk of gout, according to a recent study conducted by Arthritis Research Canada.
Social Factors that Influence Health at Root of Racial Disparities in Gout
Gout is more common in Black men and women in the United States than in white men and women, according to a new Arthritis Research Canada study. However, researchers suggest this finding is tied to social and lifestyle factors that impact health – like poverty, diet, weight etc. – rather than genetics.
Arthritis Research Canada Launches #EscapeArthritis Awareness Campaign
September is Arthritis Awareness Month. This year, we’re raising awareness about how arthritis research helps people living with different types of arthritis find solutions to the challenges raised by their diseases so they can #EscapeArthritis.
Hydroxychloroquine Deemed Safe for People Newly Diagnosed with Rheumatoid Arthritis and Lupus
Arthritis Research Canada researchers find that people with autoimmune rheumatic diseases and transplant recipients face a heightened risk of complications from COVID-19.
